Reduced dose of subcutaneous cladribine induces identical response rates but decreased toxicity in pretreated chronic lymphocytic leukaemia. Swiss Group for Clinical Cancer Research (SAKK). (Q36898519)
Jump to navigation
Jump to search
scientific article published on July 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Reduced dose of subcutaneous cladribine induces identical response rates but decreased toxicity in pretreated chronic lymphocytic leukaemia. Swiss Group for Clinical Cancer Research (SAKK). |
scientific article published on July 1998 |
Statements
1 reference
Reduced dose of subcutaneous cladribine induces identical response rates but decreased toxicity in pretreated chronic lymphocytic leukaemia. Swiss Group for Clinical Cancer Research (SAKK). (English)
1 reference
D C Betticher
1 reference
D Ratschiller
1 reference
S F Hsu Schmitz
1 reference
A von Rohr
1 reference
U Hess
1 reference
G Zulian
1 reference
M Wernli
1 reference
A Tichelli
1 reference
A Tobler
1 reference
M F Fey
1 reference
T Cerny
1 reference
1 July 1998
1 reference
1 reference
9
1 reference
7
1 reference
721-726
1 reference
Identifiers
1 reference
1 reference